Aviance Capital Management’s VanEck Biotech ETF BBH Stock Holding History

Aviance Capital Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$907K	Sell	7,055 -349	-5%	-$44.1K	0.14%	108
2018 Q4	$820K	Sell	7,404 -2,394	-24%	-$289K	0.12%	103
2018 Q3	$1.33M	Sell	9,798 -1,058	-10%	-$138K	0.13%	90
2018 Q2	$1.3M	Sell	10,856 -626	-5%	-$73.8K	0.11%	102
2018 Q1	$1.38M	Buy	11,482 +272	+2%	+$34.1K	0.11%	108
2017 Q4	$1.4M	Sell	11,210 -1,921	-15%	-$245K	0.1%	106
2017 Q3	$1.76M	Sell	13,131 -639	-5%	-$83.2K	0.12%	97
2017 Q2	$1.73M	Sell	13,770 -1,458	-10%	-$176K	0.11%	101
2017 Q1	$1.81M	Buy	+15,228	New	+$1.78M	0.1%	102

Other funds holding BBH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Aviance Capital Management's BBH Position: Q1 2019 in Review

Aviance Capital Management reduced its VanEck Biotech ETF (BBH) stake by 4.7% in Q1 2019, selling an estimated $44.1K and leaving 7,055 shares worth $907K. The position accounts for 0.14% of the portfolio, ranked #108.

Aviance Capital Management first reported a position in BBH in Q1 2017 and has held it in 9 quarters since. The position peaked at $1.81M in Q1 2017. 90 funds tracked by Wall St. Rank hold BBH as of Q1 2019.

Aviance Capital Management held 7,055 shares of VanEck Biotech ETF worth $907K as of Q1 2019.
Aviance Capital Management sold 349 VanEck Biotech ETF shares in Q1 2019, an estimated $44.1K.
VanEck Biotech ETF made up 0.14% of Aviance Capital Management's portfolio in Q1 2019, its #108 holding.
Aviance Capital Management first reported a position in VanEck Biotech ETF in Q1 2017 and has held it in 9 quarters since.
Aviance Capital Management's VanEck Biotech ETF position peaked at $1.81M in Q1 2017.
90 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2019.

Based on Aviance Capital Management's 13F filing for Q1 2019, filed 15 May 2019.